News Briefs: Supreme Court Declines PBM Fiduciary Responsibility Case

The U.S. Supreme Court declined on June 27 to hear a case that could have saddled PBMs with a fiduciary responsibility to a clients under ERISA. The case, a class action lawsuit titled John Doe v. Express Scripts, considered whether PBMs have a fiduciary duty to lower drug prices for clients, which is not the standard required by existing law or industry practice. However, some proposals currently under consideration by Congress would impose such a requirement, which could end practices such as spread pricing.

© 2022 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

bills-and-pills
August 11

New Drug Pricing Bill Could Affect Millions of Medicare Beneficiaries

READ MORE
wall-street
August 11

In 2Q, Some PBMs Report Dampened Margins, Customer Pipelines

READ MORE
insulin-bottles
August 11

Congress Won’t Act on Insulin Prices for Commercial Market

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today